Balanced Tiam1-Rac1 and RhoA Drives Proliferation and Invasion of Pancreatic Cancer Cells

Tiam1 is a rac1-specific guanine nucleotide exchange factor, and Tiam1-rac1 is involved in a number of cellular processes. Rac1 and RhoA act as molecular switches that cycle between GTP- and GDP-bound states to balance the activities of rac1 and RhoA. The downregulation of rac1 activity leads to upregulation of RhoA activity, which promotes invasion and migration of pancreatic cancers cells. At present, however, the role of Tiam1-rac1 and RhoA in pancreatic cancers is not fully understood. We found that Tiam1 was upregulated in pancreatic cancers and was significantly expressed in tumors without lymph node involvement or distant metastasis compared with cancers where there was involvement. Although Tiam1-rac1 signaling promoted pancreatic cancer cell proliferation and tumor growth via the Wnt signaling pathway in vitro and in vivo, inhibiting Tiam1-rac1 signaling did not prolong the overall survival time in vivo. This provided evidence that there was a balance between rac1 and RhoA activities in pancreatic cancers. Furthermore, only the combined inhibition of Tiam1-rac1 and RhoA had a beneficial effect on the growth of pancreatic cancers in vivo. Taken together, these results suggest that the progression of pancreatic tumors is partially controlled by the balance between Tiam1-rac1 and RhoA. Mol Cancer Res; 11(3); 230–9. ©2012 AACR.

[1]  Xi-lin Du,et al.  Clinical value of Tiam1–Rac1 signaling in primary gallbladder carcinoma , 2012, Medical Oncology.

[2]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[3]  Yu-Sun Chang,et al.  Prognostic significance of Tiam1 expression in papillary thyroid carcinoma , 2011, Virchows Archiv.

[4]  K. Taniuchi,et al.  BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation. , 2011, International journal of oncology.

[5]  R. Lang,et al.  Balanced Rac1 and RhoA activities regulate cell shape and drive invagination morphogenesis in epithelia , 2011, Proceedings of the National Academy of Sciences.

[6]  Shuang Wang,et al.  Tiam1, overexpressed in most malignancies, is a novel tumor biomarker. , 2011, Molecular medicine reports.

[7]  Xin Wang,et al.  Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma. , 2011, Oncology reports.

[8]  N. Carragher,et al.  Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. , 2011, Cancer research.

[9]  Wen Yang,et al.  Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma. , 2010, Japanese journal of clinical oncology.

[10]  S Sonderegger,et al.  Wnt signalling in implantation, decidualisation and placental differentiation--review. , 2010, Placenta.

[11]  Lan Xu,et al.  miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.

[12]  R. Buchsbaum,et al.  The role of fibroblast Tiam1 in tumor cell invasion and metastasis , 2010, Oncogene.

[13]  Ernesto J Fuentes,et al.  The Tiam1 PDZ domain couples to Syndecan1 and promotes cell-matrix adhesion. , 2010, Journal of molecular biology.

[14]  A. Scarpa,et al.  RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones , 2010, Molecular Cancer.

[15]  B. Ji,et al.  CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini. , 2010, American journal of physiology. Cell physiology.

[16]  G. Lan,et al.  Prognostic Value of Tiam1 and Rac1 Overexpression in Nasopharyngeal Carcinoma , 2009, ORL.

[17]  D. Yamazaki,et al.  Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates , 2009, Oncogene.

[18]  Yan Ding,et al.  Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients , 2009, International journal of cancer.

[19]  B. Bapat,et al.  Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells , 2008, Molecular Cancer.

[20]  David A. Williams,et al.  Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling , 2008, Cell.

[21]  R. Langer,et al.  Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer , 2008, Modern Pathology.

[22]  H. Kocher,et al.  Analysis of mortality rates for pancreatic cancer across the world. , 2008, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[23]  J. Settleman,et al.  p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho , 2006, Cell.

[24]  U. Herbrand,et al.  p190-RhoGAP as an integral component of the Tiam1/Rac1-induced downregulation of Rho , 2006, Biological chemistry.

[25]  H. Clevers,et al.  The Rac Activator Tiam1 Is a Wnt-responsive Gene That Modifies Intestinal Tumor Development* , 2006, Journal of Biological Chemistry.

[26]  John G. Collard,et al.  The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model , 2005, Oncogene.

[27]  B. Bapat,et al.  Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of β-catenin and TCF/LEF-mediated transcriptional activation , 2004, Oncogene.

[28]  Mami Terao,et al.  Roles of STEF/Tiam1, guanine nucleotide exchange factors for Rac1, in regulation of growth cone morphology , 2003, Molecular and Cellular Neuroscience.

[29]  John G. Collard,et al.  Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours , 2002, Nature.

[30]  P. McCrea,et al.  Tiam1 Overexpression Potentiates Heregulin-induced Lymphoid Enhancer Factor-1/β-Catenin Nuclear Signaling in Breast Cancer Cells by Modulating the Intercellular Stability* , 2001, The Journal of Biological Chemistry.

[31]  John G. Collard,et al.  Rac Downregulates Rho Activity: Reciprocal Balance between Both Gtpases Determines Cellular Morphology and Migratory Behavior , 1999 .

[32]  John G. Collard,et al.  Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. , 1997, Science.

[33]  John G. Collard,et al.  The Guanine Nucleotide Exchange Factor Tiam1 Affects Neuronal Morphology; Opposing Roles for the Small GTPases Rac and Rho , 1997, The Journal of cell biology.

[34]  Shuang Wang,et al.  Tiam1 is associated with hepatocellular carcinoma metastasis , 2013, International journal of cancer.

[35]  S. Dosso,et al.  Chemotherapy in patients with advanced pancreatic cancer: too close to death? , 2012, Supportive Care in Cancer.

[36]  M. Schmidt,et al.  Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1. , 2009, Oncology reports.

[37]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[38]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.

[39]  G. Habets,et al.  Activation of Rac1 by human Tiam1. , 2000, Methods in enzymology.